药明合联(02268)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02268 药明合联

交易中 12-23 09:49:38

66.500

-0.500

-0.75%

最高67.450	最低65.100	成交量96.35万
今开66.000	昨收67.000	日振幅3.51%
总市值833.25亿	流通市值833.25亿	总股本12.53亿
成交额6,338万	换手率0.08%	流通股本12.53亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02268","market":"HK","secType":"STK","nameCN":"药明合联","latestPrice":66.5,"timestamp":1766454572340,"preClose":67,"halted":0,"volume":963452,"delay":0,"floatShares":1253000000,"shares":1253000000,"eps":0.9873600997114436,"marketStatus":"交易中","change":-0.5,"latestTime":"12-23 09:49:38","open":66,"high":67.45,"low":65.1,"amount":63380174,"amplitude":0.035075,"askPrice":66.6,"askSize":500,"bidPrice":66.5,"bidSize":20000,"shortable":3,"etf":0,"ttmEps":1.1290474931360883,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1766462400000},"marketStatusCode":2,"adr":0,"listingDate":1700150400000,"exchange":"SEHK","adjPreClose":67,"openAndCloseTimeList":[[1766453400000,1766462400000],[1766466000000,1766476800000]],"volumeRatio":3.60112,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02268","defaultTab":"news","newsList":[{"id":"2593459619","title":"每日卖空追踪 | 药明合联 12月22日卖空量成交22.5万股，卖空比例为2.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593459619","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593459619?lang=zh_cn&edition=full","pubTime":"2025-12-22 16:30","pubTimestamp":1766392229,"startTime":"0","endTime":"0","summary":"药明合联北京时间12月22日，跌4.29%，卖空量成交22.5万股，较上一交易日减少75.69%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163444a4699583&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251222163444a4699583&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02268","SG9999014674.SGD","LU2488822045.USD","BK1141"],"gpt_icon":0},{"id":"2593459682","title":"药明合联盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593459682","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593459682?lang=zh_cn&edition=full","pubTime":"2025-12-22 13:10","pubTimestamp":1766380238,"startTime":"0","endTime":"0","summary":"2025年12月22日下午盘13时10分，药明合联股票出现异动，股价快速跳水5.00%。截至发稿，该股报66.500港元/股，成交量256.18万股，换手率0.20%，振幅5.14%。资金方面，该股资金流入5868.94万港元，流出7578.99万港元。药明合联股票所在的生物技术行业中，整体跌幅为0.92%。其相关个股中，北海康成-B、中生北控生物科技、迈博药业-B涨幅较大，振幅较大的相关个股有华昊中天医药-B、华生物-B、加科思-B，振幅分别为23.40%、16.23%、14.35%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122213103897a0884a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025122213103897a0884a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","SG9999014674.SGD","02268","LU2488822045.USD"],"gpt_icon":0},{"id":"2592044139","title":"医药股集体走高 药明生物(02269)涨5.93% 机构料明年板块稳中向好态势延续","url":"https://stock-news.laohu8.com/highlight/detail?id=2592044139","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592044139?lang=zh_cn&edition=full","pubTime":"2025-12-19 10:23","pubTimestamp":1766111038,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药股集体走高，药明生物 涨5.93%，药明合联涨4.56%，君实生物涨4.54%，康诺亚-B涨4.19%，荣昌生物涨3.98%，科伦博泰生物-B涨4.00%，泰格医药涨4.30%，复宏汉霖涨3.72%，诺诚健华涨3.26%。交银国际发布医药行业周报，展望2026年，该机构认为板块稳中向好态势延续，但影响市场表现的核心因素或呈分化态势，后续选股逻辑或将重回基本面和估值，即关注存在基本面预期差、当前仍被低估的个股。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971870","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","LU1242518931.SGD","LU0326950275.SGD","02162","LU0856984785.SGD","LU1688375341.USD","02269","LU1242518857.USD","LU2328871848.SGD","SG9999002562.SGD","BK1161","LU0181495838.USD","06990","LU0196878994.USD","09969","LU1880383366.USD","BK1141","BK1587","159938","LU2488822045.USD","LU0708995583.HKD","LU1969619763.USD","BK1610","02268","BK1574","LU0823426480.USD","LU0359202008.SGD","LU0051755006.USD","LU0348735423.USD","LU0359201612.USD","BK1576","LU0039217434.USD","LU0052750758.USD","LU0516422366.SGD","HK0000165453.HKD","BK1521","03347","SG9999014674.SGD","02696","LU0417516738.SGD","LU0588546209.SGD","LU0823426308.USD","01877","LU0417516902.SGD","IE00B0JY6N72.USD","LU0348825331.USD","09995","LU0327786744.USD","LU0819121731.USD","LU0572944931.SGD"],"gpt_icon":0},{"id":"2592513686","title":"【券商聚焦】交银国际：临近年末 续看好新BD交易集中落地机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2592513686","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592513686?lang=zh_cn&edition=full","pubTime":"2025-12-19 09:20","pubTimestamp":1766107245,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际发布医药行业周报，本周多项超10亿美元的BD交易相继落地，合作伙伴既有MNC也有中小型生物科技公司。临近年末，该机构继续看好新BD交易集中落地机会。展望2026 年，该机构认为板块稳中向好态势延续，但影响市场表现的核心因素或呈分化态势，后续选股逻辑或将重回基本面和估值，即关注存在基本面预期差、当前仍被低估的个股。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/YzM1MzBiNWM5MmUxNDYxMGFiODk0MWI5MWJmNTU3YjMxMTA4MTkwNzI1ODY3.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/YzM1MzBiNWM5MmUxNDYxMGFiODk0MWI5MWJmNTU3YjMxMTA4MTkwNzI1ODY3.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971853","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01530","LU0348783233.USD","LU0417516902.SGD","LU1770034418.SGD","LU2328871848.SGD","LU2488822045.USD","BK1588","SG9999014674.SGD","LU0417516738.SGD","LU2476274720.SGD","IE00B543WZ88.USD","01099","BK1197","HK0000165453.HKD","BK1583","LU0588546209.SGD","BK1147","BK1191","LU0561508036.HKD","LU0348735423.USD","LU1303224171.USD","06160","03329","LU1115378108.SGD","01789","LU0634319403.HKD","02367","LU0307460666.USD","LU1720050803.USD","BK1617","LU0348784397.USD","LU0348825331.USD","09926","LU0348766576.USD","LU2778985437.USD","02268","LU0417516571.SGD","LU1794554557.SGD","BK1500","IE00B5MMRT66.SGD","LU2476274308.USD","BK1593","LU0540923850.HKD","LU1251922891.USD","LU2399975544.HKD","BK1585","02196","02228","03933","09688"],"gpt_icon":0},{"id":"2592513924","title":"创新药概念逆市上扬 石药集团(01093)午后升幅扩至近6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592513924","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592513924?lang=zh_cn&edition=full","pubTime":"2025-12-18 13:21","pubTimestamp":1766035316,"startTime":"0","endTime":"0","summary":"金吾财讯 | 创新药概念逆市上扬，石药集团 升5.98%，药明生物升1.97%，药明合联升1.56%，先声药业升1.51%，药明康德升1.28%。开源证券指出，当前纳入医保+商保的创新药大多处于未放量以及低基数阶段，随着医保支持创新药的政策红利持续释放，我们认为纳入双目录的创新药收入有望快速提升，患者有望持续受益，同时相关创新药企也随之迎来弹性增长。","market":"hk","thumbnail":"https://static.szfiu.com/news/20241108/ZDQyZmM0MDNhYTRlOWFhOWE0NDBjZGFmOTc4ZmU3NDQzMjc2MzA4MTk4NA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZDQyZmM0MDNhYTRlOWFhOWE0NDBjZGFmOTc4ZmU3NDQzMjc2MzA4MTk4NA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971799","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B031HY20.USD","IE00B5MMRT66.SGD","02269","SG9999002463.SGD","IE00BZ08YT58.USD","LU0572944931.SGD","SG9999002562.SGD","159992","LU0501845795.SGD","01093","BK1610","IE00BZ08YR35.GBP","06978","LU1794554557.SGD","BK1515","LU0307460666.USD","BK1583","LU1046422090.SGD","02359","BK1589","LU0456827905.SGD","LU0315179316.USD","IE00B543WZ88.USD","LU0140636845.USD","02096","LU1328277881.USD","LU1152091754.HKD","BK1191","LU1242518857.USD","LU3063872942.SGD","LU0320764599.SGD","LU0052750758.USD","BK1574","LU0039217434.USD","LU1008478684.HKD","LU1226287875.USD","LU1813983027.USD","LU0051755006.USD","LU1242518931.SGD","LU0181495838.USD","LU1807302812.USD","02268","LU1688375341.USD","LU0588546209.SGD","LU0348825331.USD","LU1226287792.SGD","LU0856984785.SGD","IE0008369823.USD","IE00BZ08YS42.EUR","LU0348735423.USD"],"gpt_icon":0},{"id":"2592616019","title":"药明合联12月16日主力净流出425.2万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2592616019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592616019?lang=zh_cn&edition=full","pubTime":"2025-12-16 16:15","pubTimestamp":1765872935,"startTime":"0","endTime":"0","summary":"12月16日, 药明合联股价跌0.73%，报收68.30元，成交金额3.2亿元，换手率0.38%，振幅4.65%，量比0.73。药明合联今日主力资金净流出425.2万元，上一交易日主力净流入544.5万元。该股近5个交易日下跌1.01%，主力资金累计净流入1650.0万元，其中2个交易日为股价上涨时净流出；近20日主力资金累计净流入7696.8万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216161818a4518c08&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251216161818a4518c08&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","02268","SG9999014674.SGD","BK1141"],"gpt_icon":0},{"id":"1132076924","title":"港股生物医药股盘初走高！昭衍新药涨超7%，荣昌生物涨超6%","url":"https://stock-news.laohu8.com/highlight/detail?id=1132076924","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132076924?lang=zh_cn&edition=full","pubTime":"2025-12-11 09:38","pubTimestamp":1765417090,"startTime":"0","endTime":"0","summary":"12月11日，港股生物医药股盘初走高，$荣昌生物(09995)$涨超4%，$康方生物(09926)$、$药明生物(02269)$、$药明合联(02268)$、$药明康德(02359)$均涨超2%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"5863422ac1bd6abc1efb51c1b10288a9","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268","09926","09995","09939","06127","02269"],"gpt_icon":0},{"id":"2590553896","title":"药明合联12月10日获主力加仓667.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590553896","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590553896?lang=zh_cn&edition=full","pubTime":"2025-12-10 16:16","pubTimestamp":1765354563,"startTime":"0","endTime":"0","summary":"12月10日, 药明合联股价涨1.29%，报收70.50元，成交金额3.0亿元，换手率0.34%，振幅4.02%，量比0.94。药明合联今日主力资金净流入667.0万元，连续5日净流入，上一交易日主力净流入3219.0万元。该股近5个交易日上涨11.70%，主力资金累计净流入6136.6万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入7575.0万元，其中净流入天数为14日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210162311a72f4777&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251210162311a72f4777&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","SG9999014674.SGD","LU2488822045.USD","02268"],"gpt_icon":0},{"id":"2590303708","title":"重磅事件落地！商业化+出海提速，板块调整后弹性更突出","url":"https://stock-news.laohu8.com/highlight/detail?id=2590303708","media":"浙商证券融资融券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590303708?lang=zh_cn&edition=full","pubTime":"2025-12-10 13:02","pubTimestamp":1765342962,"startTime":"0","endTime":"0","summary":"关注研发实力强且已有商业化创新药产品上市的企业；CXO及生命科学上游产业链。CXO一体化龙头公司如药明康德，保持业绩持续向好趋势，业绩保持较快增长。投资者据此操作，风险自负。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512101335329534f1c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202512101335329534f1c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1583","06160","06821","BK1141","BK1574","LU1046422090.SGD","LU2045819591.USD","06978","02268","LU0052750758.USD","03759","BK1576","LU2125910500.SGD","02359","LU2242644610.SGD","BK1161","LU0708995583.HKD","LU0320764599.SGD","01801"],"gpt_icon":0},{"id":"2590532237","title":"每日卖空追踪 | 药明合联 12月09日卖空量成交21万股，卖空比例为3.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590532237","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590532237?lang=zh_cn&edition=full","pubTime":"2025-12-09 16:30","pubTimestamp":1765269028,"startTime":"0","endTime":"0","summary":"药明合联北京时间12月09日，涨3.34%，卖空量成交21万股，较上一交易日减少15.66%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120916342997982657&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025120916342997982657&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","LU2488822045.USD","BK1141","02268"],"gpt_icon":0},{"id":"2590322360","title":"药明合联12月09日获主力加仓3219.0万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590322360","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590322360?lang=zh_cn&edition=full","pubTime":"2025-12-09 16:15","pubTimestamp":1765268118,"startTime":"0","endTime":"0","summary":"12月09日, 药明合联股价涨3.34%，报收69.60元，成交金额4.7亿元，换手率0.54%，振幅5.35%，量比1.93。药明合联今日主力资金净流入3219.0万元，连续4日净流入，上一交易日主力净流入156.7万元。近一年数据显示，该股主力连续4日净流入后，次日上涨概率为42.86%，平均涨幅为1.41%。该股近5个交易日上涨6.80%，主力资金累计净流入4884.3万元，其中2个交易日为股价下跌时净流入；近20日主力资金累计净流入6668.9万元，其中净流入天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209161636953311c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251209161636953311c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SG9999014674.SGD","LU2488822045.USD","02268","BK1141"],"gpt_icon":0},{"id":"2590393913","title":"招银国际：2025医保目录公布延续支持创新 料CXO业下半年修复","url":"https://stock-news.laohu8.com/highlight/detail?id=2590393913","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590393913?lang=zh_cn&edition=full","pubTime":"2025-12-09 10:03","pubTimestamp":1765245827,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，招银国际发布研报称，2025年版基本医保目录以及首版商保目录发布，延续支持创新，料CXO行业有望在下半年迎来业绩修复。推荐买入三生制药(01530)、固生堂(02273)、药明合联(02268)、巨子生物(02367)、信达生物(01801)、中国生物制药(01177)。报告表示，多家企业的核心创新品种获纳入医保。该行认为，宏观环境及老龄化的挑战下，医保收支压力仍在，关注国家集采续约。尽管首版商保目录短期对于产品销售的拉动有限，由于商业保险的规模不大，认为商保目录的意义重大，或将开启中国商业医疗保险扩容的道路，成为中国多元化支付体系发展开端。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1379143.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2488822045.USD","LU0502904849.HKD","HK0000165453.HKD","IE00BZ08YT58.USD","02268","BK1515","BK1583","LU1969619763.USD","BK1191","02367","BK1161","LU2097828474.EUR","LU2097828631.EUR","LU0455707207.USD","IE00BZ08YS42.EUR","SG9999014674.SGD","CXO","01177","LU2242644610.SGD","BK1141","LU2097828805.USD","01801","02273","LU2328871848.SGD","01530","BK1589","BK1593","LU2097828557.USD","BK1207","BK1521","SG9999004311.SGD","BK1219","IE00BZ08YR35.GBP","LU2097828714.EUR"],"gpt_icon":0},{"id":"2590398455","title":"创新药概念股盘初强势 歌礼制药-B(01672)涨20.73% 机构指政策鼓励创新药发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2590398455","media":"金吾财讯","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590398455?lang=zh_cn&edition=full","pubTime":"2025-12-09 09:38","pubTimestamp":1765244314,"startTime":"0","endTime":"0","summary":"中信证券表示，2025年12月7日，2025创新药高质量发展大会在广州举行，国家医保局现场发布了2025年《国家基本医疗保险、生育保险和工伤保险药品目录》及《商业健康保险创新药品目录》。该机构认为，国家医保谈判成功率创历史新高，商保目录有望成为重要增量，政策鼓励创新药发展。看好相关创新药及制药企业。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MmRhZGRhNjQ0NTZmM2ZiNTY3MTMzODA5NjE3MTg=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1971163","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","BK1141","02096","BK1191","BK1161","SG9999015986.USD","01672","IE00BGHQDM52.EUR","SG9999015952.SGD","LU2488822045.USD","IE00BVYPNQ40.USD","IE00BVYPNP33.GBP","BK1583","SG9999014674.SGD","SG9999015945.SGD","02268","02157","BK1593","SG9999004220.SGD","159992","BK1574","01952","01477","IE00BMCWC346.EUR","06978","IE00BYV24P56.USD","00867","SG9999015978.USD"],"gpt_icon":0},{"id":"2589233996","title":"ADC药物浪潮下，凯莱英、药明合联等CDMO企业产能角逐正酣","url":"https://stock-news.laohu8.com/highlight/detail?id=2589233996","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589233996?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:31","pubTimestamp":1765182717,"startTime":"0","endTime":"0","summary":"据悉，药明合联无锡基地目前抗体及偶联原液产能总产能约1.1万升，制剂总产能将计划在2027年扩展至3500万瓶。皓元医药ADC原液年产能可达1500kg，重庆抗体偶联CDMO基地配备1条抗体蛋白原液产线，年设计产能12万升。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208163650979615fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208163650979615fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06821","SG9999014674.SGD","02268","BK1191","LU2488822045.USD","BK1141"],"gpt_icon":0},{"id":"2590368632","title":"每日卖空追踪 | 药明合联 12月08日卖空量成交8.1万股，卖空比例为3.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2590368632","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590368632?lang=zh_cn&edition=full","pubTime":"2025-12-08 16:30","pubTimestamp":1765182627,"startTime":"0","endTime":"0","summary":"药明合联北京时间12月08日，跌0.22%，卖空量成交8.1万股，较上一交易日减少86.64%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208163413a43afa5d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208163413a43afa5d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","02268","BK1141","SG9999014674.SGD"],"gpt_icon":0},{"id":"2589402852","title":"【券商聚焦】交银国际：医药行业短期催化剂充足 长期继续看好创新主线","url":"https://stock-news.laohu8.com/highlight/detail?id=2589402852","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589402852?lang=zh_cn&edition=full","pubTime":"2025-12-05 10:38","pubTimestamp":1764902337,"startTime":"0","endTime":"0","summary":"金吾财讯 | 交银国际表示，2025年10月以来，内资通过港股通持有医药股的比例小幅下降，外资持仓从年中起亦呈回落态势，但内外资加大创新药布局的大方向不变。而外资则更积极，聚焦创新主线中的龙头及产业链上游，包括恒瑞医药、君实生物和荣昌生物等创新药，及康龙化成、药明康德和泰格医药等CXO标的。12月，行业仍有充足催化剂，包括各项学术大会、医保谈判结果公布、美联储潜在降息等，板块投资情绪有望稳中有升。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWU1MjY1NDI2Mjg5NDIzOQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1970976","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02196","BK1593","LU0417516738.SGD","01530","02367","06160","LU0561508036.HKD","LU0348825331.USD","LU1794554557.SGD","LU1303224171.USD","LU2778985437.USD","LU2399975544.HKD","BK1583","09926","03933","02228","BK1588","LU2488822045.USD","LU0348766576.USD","BK1500","BK1161","IE00B5MMRT66.SGD","LU0634319403.HKD","BK1617","BK1141","SG9999014674.SGD","BK1197","LU0417516902.SGD","LU0640798160.USD","HK0000165453.HKD","LU2476274308.USD","LU2328871848.SGD","LU0417516571.SGD","IE00B543WZ88.USD","BK1585","02268","09688","LU0588546209.SGD","01099","LU1969619763.USD","LU0540923850.HKD","BK1147","LU0348827113.USD","LU2476274720.SGD","03329","IE00BPRC5H50.USD","LU1251922891.USD","01789","SG9999004311.SGD","LU1770034418.SGD"],"gpt_icon":1},{"id":"2589852755","title":"交银国际：中国医药1-8批国采接续规则或温和 短期催化剂充足","url":"https://stock-news.laohu8.com/highlight/detail?id=2589852755","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589852755?lang=zh_cn&edition=full","pubTime":"2025-12-05 10:18","pubTimestamp":1764901122,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，交银国际发布研报称，本周恒生医疗保健指数涨0.5%，跑输大市。其中，生物药、处方药及器械板块表现较优于其他板块。本周内资偏向防御，倾向获利了结，主要加仓内生增长稳定的传统及低估创新药厂。而外资则较积极，聚焦创新主线中的龙头及产业链上游，包括创新药及CXO标的。1-8批集采接续采购规则转变为询价模式，交银国际认为此规则下整体降价幅度或有限，对港股处方药厂的影响或小于预期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1378013.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0175","BK0082","BK1191","SG9999014674.SGD","HK0000165453.HKD","BK0185","BK1593","LU2488822045.USD","02096","600056","BK1574","01530","BK1587","BK0010","00013","BK0028","BK1583","BK1147","BK1588","BK1161","BK0188","BK1141","02268","BK0250","03329","06996"],"gpt_icon":0},{"id":"1136002031","title":"药明合联（2268）更新2025年11月股份变动月报表，总股本小幅增加","url":"https://stock-news.laohu8.com/highlight/detail?id=1136002031","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136002031?lang=zh_cn&edition=full","pubTime":"2025-12-04 17:19","pubTimestamp":1764839978,"startTime":"0","endTime":"0","summary":"药明合联生物技术有限公司于2025年12月4日发布2025年11月股份变动月报表。报告显示，截至2025年11月30日，公司注册股本维持在10,000,000,000股普通股，面值0.00005美元，法定/注册股本总额保持500,000美元不变。无股份购回、注销或库存股变动记录。此外，公司董事会于过去数次会议批准了一项2024年股份计划，截至报告期末，根据该计划尚可发行普通股合计10,285,226股，本月内并未新增发行。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02268"],"gpt_icon":0},{"id":"2588002629","title":"每日卖空追踪 | 药明合联 12月04日卖空量成交5.75万股，卖空比例为1.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588002629","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588002629?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:30","pubTimestamp":1764837030,"startTime":"0","endTime":"0","summary":"药明合联北京时间12月04日，涨7.51%，卖空量成交5.75万股，较上一交易日减少89.53%更多个股卖空数据请看下面视窗：卖空数据是观测市场多空博弈的关键指标：短期可反映市场情绪，高卖空比例预示看空预期，但极端值可能触发轧空反弹；长期结合基本面恶化则预警下行风险。需注意其局限性：卖空行为包含对冲需求，未必单纯看空；机构可能通过衍生品做空未体现在数据中，且散户跟风易扭曲信号。股市有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163444952a7beb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204163444952a7beb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2488822045.USD","BK1141","02268","SG9999014674.SGD"],"gpt_icon":0},{"id":"2588200260","title":"药明合联12月04日主力净流入1562.4万元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2588200260","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588200260?lang=zh_cn&edition=full","pubTime":"2025-12-04 16:15","pubTimestamp":1764836138,"startTime":"0","endTime":"0","summary":"12月04日, 药明合联股价涨7.51%，报收68.00元，成交金额3.7亿元，换手率0.45%，振幅8.54%，量比1.47。药明合联今日主力资金净流入1562.4万元，上一交易日主力净流出585.3万元。该股近5个交易日上涨4.81%，主力资金累计净流入998.4万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入5475.7万元，其中净流入天数为13日。该股主力净额占比0.02%，港股市场排名263/2683。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204161845952a7294&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251204161845952a7294&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02268","SG9999014674.SGD","LU2488822045.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://wuxixdc.com","stockEarnings":[{"period":"1week","weight":-0.0262},{"period":"1month","weight":0.0083},{"period":"3month","weight":-0.1178},{"period":"6month","weight":0.601},{"period":"1year","weight":1.0938},{"period":"ytd","weight":1.186}],"compareEarnings":[{"period":"1week","weight":0.0067},{"period":"1month","weight":0.0231},{"period":"3month","weight":-0.0137},{"period":"6month","weight":0.0542},{"period":"1year","weight":0.3084},{"period":"ytd","weight":0.2862}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"药明合联生物技术有限公司是一家主要从事提供提供抗体偶联药物（ADC）及其他生物偶联药物的全面合同研究、开发及制造组织（CRDMO）服务的投资控股公司。该公司的服务包括生物偶联药物、单克隆抗体中间体及生物偶联药物相关连接子及有效载荷的发现、工艺开发及优良生产质量管理规范（GMP）生产。该公司透过按有偿服务（FFS）基准的合约和按全时当量（FTE）基准的合约向客户提供CRDMO服务。该公司主要在国内市场、北美、欧洲和世界其他地区市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":0.010265},{"month":2,"riseRate":0.666667,"avgChangeRate":0.058284},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.010372},{"month":4,"riseRate":0.555556,"avgChangeRate":0.03555},{"month":5,"riseRate":0.333333,"avgChangeRate":0.006014},{"month":6,"riseRate":0.4,"avgChangeRate":-0.032735},{"month":7,"riseRate":0.4,"avgChangeRate":0.011785},{"month":8,"riseRate":0.4,"avgChangeRate":-0.114063},{"month":9,"riseRate":0.333333,"avgChangeRate":0.019767},{"month":10,"riseRate":0.777778,"avgChangeRate":0.151657},{"month":11,"riseRate":0.333333,"avgChangeRate":0.008796},{"month":12,"riseRate":0.111111,"avgChangeRate":-0.068876}],"exchange":"SEHK","name":"药明合联","nameEN":"WUXI XDC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"药明合联(02268)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供药明合联(02268)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"药明合联,02268,药明合联股票,药明合联股票老虎,药明合联股票老虎国际,药明合联行情,药明合联股票行情,药明合联股价,药明合联股市,药明合联股票价格,药明合联股票交易,药明合联股票购买,药明合联股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"药明合联(02268)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供药明合联(02268)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}